Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google ...

For several decades, the prevalence of steatotic liver disease (SLD) has been steadily increasing.1 Alterations in hepatic ...

There is a 'valley of death' in European research and innovation, says CEO of Novo Nordisk Foundation ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have other untapped potentials to reduce health risks.